Literature DB >> 20407891

Analysis of E. coli K5 capsular polysaccharide heparosan.

Mellisa Ly1, Zhenyu Wang, Tatiana N Laremore, Fuming Zhang, Weihong Zhong, Dennis Pu, Dmitri V Zagorevski, Jonathan S Dordick, Robert J Linhardt.   

Abstract

Heparosan is the key precursor for the preparation of bioengineered heparin, a potential replacement for porcine intestinal heparin, an important anticoagulant drug. The molecular weight (MW) distribution of heparosan produced by the fermentation of E. coli K5 was investigated. Large-slab isocratic and mini-slab gradient polyacrylamide gel electrophoresis (PAGE) were used to analyze the MW and polydispersity of heparosan. A preparative method that allowed fractionation by continuous-elution PAGE was used to obtain heparosan MW standards. The MWs of the heparosan standards were determined by electrospray ionization Fourier-transform mass spectrometry (ESI-FT-MS). A ladder of the standards was then used to determine the MW properties of polydisperse heparosan samples. Unbleached and bleached heparosan produced by fermentation of E. coli K5 had similar number-averaged MWs (M(N)), weight-averaged MWs (M(W)), and MW ranges of 3,000 to 150,000 Da.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20407891      PMCID: PMC3390146          DOI: 10.1007/s00216-010-3679-7

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  22 in total

1.  2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity.

Authors:  Robert J Linhardt
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

Review 2.  Fondaparinux: pharmacology and clinical experience in cardiovascular medicine.

Authors:  V Toschi; M Lettino
Journal:  Mini Rev Med Chem       Date:  2007-04       Impact factor: 3.862

Review 3.  Structural insights into biological roles of protein-glycosaminoglycan interactions.

Authors:  Rahul Raman; V Sasisekharan; Ram Sasisekharan
Journal:  Chem Biol       Date:  2005-03

4.  Chemoenzymatic synthesis of classical and non-classical anticoagulant heparan sulfate polysaccharides.

Authors:  Balagurunathan Kuberan; David L Beeler; Miroslaw Lech; Zhengliang L Wu; Robert D Rosenberg
Journal:  J Biol Chem       Date:  2003-09-29       Impact factor: 5.157

5.  Purification of the Escherichia coli K5 capsular polysaccharide and use of high-performance capillary electrophoresis to qualitative and quantitative monitor the process.

Authors:  Nicola Volpi
Journal:  Electrophoresis       Date:  2004-10       Impact factor: 3.535

6.  Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives.

Authors:  R E Edens; A al-Hakim; J M Weiler; D G Rethwisch; J Fareed; R J Linhardt
Journal:  J Pharm Sci       Date:  1992-08       Impact factor: 3.534

Review 7.  Heparin-protein interactions.

Authors:  Ishan Capila; Robert J Linhardt
Journal:  Angew Chem Int Ed Engl       Date:  2002-02-01       Impact factor: 15.336

Review 8.  Heparin-binding domains in vascular biology.

Authors:  Eva M Muñoz; Robert J Linhardt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-01       Impact factor: 8.311

9.  The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin.

Authors:  W F Vann; M A Schmidt; B Jann; K Jann
Journal:  Eur J Biochem       Date:  1981-05-15

10.  Metachromatic activity of heparin and heparin fragments.

Authors:  A C Grant; R J Linhardt; G L Fitzgerald; J J Park; R Langer
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

View more
  22 in total

1.  Escherichia coli K5 heparosan fermentation and improvement by genetic engineering.

Authors:  Zhenyu Wang; Jonathan S Dordick; Robert J Linhardt
Journal:  Bioeng Bugs       Date:  2011 Jan-Feb

2.  Cyclic AMP (cAMP) Receptor Protein-cAMP Complex Regulates Heparosan Production in Escherichia coli Strain Nissle 1917.

Authors:  Huihui Yan; Feifei Bao; Liping Zhao; Yanying Yu; Jiaqin Tang; Xianxuan Zhou
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

3.  High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification.

Authors:  Payel Datta; Li Fu; Paul Brodfuerer; Jonathan S Dordick; Robert J Linhardt
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-22       Impact factor: 4.813

4.  Sequence analysis and domain motifs in the porcine skin decorin glycosaminoglycan chain.

Authors:  Xue Zhao; Bo Yang; Kemal Solakyildirim; Kemal Solakylidirim; Eun Ji Joo; Toshihiko Toida; Kyohei Higashi; Robert J Linhardt; Lingyun Li
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

5.  Control of the heparosan N-deacetylation leads to an improved bioengineered heparin.

Authors:  Zhenyu Wang; Bo Yang; Zhenqing Zhang; Mellisa Ly; Majde Takieddin; Shaker Mousa; Jian Liu; Jonathan S Dordick; Robert J Linhardt
Journal:  Appl Microbiol Biotechnol       Date:  2011-04-12       Impact factor: 4.813

6.  Glycosaminoglycan characterization by electrospray ionization mass spectrometry including fourier transform mass spectrometry.

Authors:  Tatiana N Laremore; Franklin E Leach; Kemal Solakyildirim; I Jonathan Amster; Robert J Linhardt
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

7.  Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin.

Authors:  Zhongping Xiao; Britney R Tappen; Mellisa Ly; Wenjing Zhao; Lauren P Canova; Huashi Guan; Robert J Linhardt
Journal:  J Med Chem       Date:  2010-12-17       Impact factor: 7.446

8.  Domain structure elucidation of human decorin glycosaminoglycans.

Authors:  Tatiana N Laremore; Mellisa Ly; Zhenqing Zhang; Kemal Solakyildirim; Scott A McCallum; Richard T Owens; Robert J Linhardt
Journal:  Biochem J       Date:  2010-10-15       Impact factor: 3.857

9.  Controlled Photochemical Depolymerization of K5 Heparosan, a Bioengineered Heparin Precursor.

Authors:  Kyohei Higashi; Mellisa Ly; Zhenyu Wang; Sayaka Masuko; Ujjwal Bhaskar; Eric Sterner; Fuming Zhang; Toshihiko Toida; Jonathan S Dordick; Robert J Linhardt
Journal:  Carbohydr Polym       Date:  2011-08-01       Impact factor: 9.381

10.  Molecular Mass Characterization of Glycosaminoglycans with Different Degrees of Sulfation in Bioengineered Heparin Process by Size Exclusion Chromatography.

Authors:  Zhenyu Wang; Fuming Zhang; Jonathan S Dordick; Robert J Linhardt
Journal:  Curr Anal Chem       Date:  2012-10-01       Impact factor: 1.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.